Caricamento...
Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
OBJECTIVE: The objective of this clinical trial is to study the effectiveness of administering recombinant activated factor VII (rFVIIa) in reducing the amount of bleeding and the need for homologous blood and products transfusion in cardiac surgical coronary revascularization procedures done under...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3757804/ https://ncbi.nlm.nih.gov/pubmed/24015134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1658-354X.115364 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|